Venus Concept Inc. to Present at the H.C. Wainwright 25th Annual Global Investment Conference
September 06 2023 - 7:30AM
Venus Concept Inc. (“Venus Concept” or the
“Company”) (NASDAQ: VERO), a global medical aesthetic
technology leader, today announced that management will participate
in the H.C. Wainwright 25th Annual Global Investment Conference,
which is being held virtually and in person at the Lotte New York
Palace in New York, NY from September 11th-13th.
Management’s presentation will be available on
demand beginning on Monday, September 11th at 7:00 a.m. Eastern
Time. Management will participate in investor meetings on Tuesday,
September 12th.
An audio webcast of the presentation will be
accessible under the “Events” section of the Company's investor
relations website at https://ir.venusconcept.com/. An archive of
the webcast will be available for replay following the
conference.
About Venus Concept
Venus Concept is an innovative global medical
aesthetic technology leader with a broad product portfolio of
minimally invasive and non-invasive medical aesthetic and hair
restoration technologies and reach in over 60 countries and 14
direct markets. Venus Concept’s product portfolio consists of
aesthetic device platforms, including Venus Versa, Venus Legacy,
Venus Velocity, Venus Fiore, Venus Viva, Venus Glow, Venus Bliss,
Venus BlissMAX, Venus Epileve, Venus Viva MD and AI.ME. Venus
Concept’s hair restoration systems include NeoGraft® and the ARTAS
iX® Robotic Hair Restoration system. Venus Concept has been backed
by leading healthcare industry growth equity investors including EW
Healthcare Partners (formerly Essex Woodlands), HealthQuest
Capital, Longitude Capital Management, Aperture Venture Partners,
and Masters Special Situations.
Investor Relations Contact:
ICR Westwicke on behalf of Venus Concept:
Mike Piccinino, CFA
VenusConceptIR@westwicke.com
Venus Concept (NASDAQ:VERO)
Historical Stock Chart
From Jul 2024 to Aug 2024
Venus Concept (NASDAQ:VERO)
Historical Stock Chart
From Aug 2023 to Aug 2024